Free Trial

Anixa Biosciences (ANIX) Short Interest Ratio & Short Volume

Anixa Biosciences logo
$2.41 -0.17 (-6.59%)
As of 01/17/2025 04:00 PM Eastern

Anixa Biosciences Short Interest Data

Anixa Biosciences (ANIX) has a short interest of 336,300 shares, representing 1.10% of the float (the number of shares available for trading by the public). This marks a 4.15% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.3, indicating that it would take 3.3 days of the average trading volume of 88,561 shares to cover all short positions.

Current Short Interest
336,300 shares
Previous Short Interest
322,900 shares
Change Vs. Previous Month
+4.15%
Dollar Volume Sold Short
$780,216.00
Short Interest Ratio
3.3 Days to Cover
Last Record Date
December 31, 2024
Outstanding Shares
32,180,000 shares
Float Size
30,550,000 shares
Short Percent of Float
1.10%
Today's Trading Volume
145,153 shares
Average Trading Volume
88,561 shares
Today's Volume Vs. Average
164%
Short Selling Anixa Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Anixa Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ANIX Short Interest Over Time

ANIX Days to Cover Over Time

ANIX Percentage of Float Shorted Over Time

Anixa Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/2024336,300 shares $780,216.00 +4.2%1.1%3.3 $2.32
12/15/2024322,900 shares $920,265.00 -12.5%1.1%3.6 $2.85
11/30/2024369,000 shares $1.22 million -10.4%1.2%4.1 $3.30
11/15/2024411,600 shares $1.27 million -2.4%1.4%4.8 $3.08
10/31/2024421,900 shares $1.48 million -28.9%1.4%5.6 $3.50
10/15/2024593,700 shares $1.80 million -5.3%1.9%9 $3.03
9/30/2024627,200 shares $1.98 million -8.9%2.1%6.5 $3.15
9/15/2024688,800 shares $2.31 million -3.2%2.3%7.1 $3.35
8/31/2024711,600 shares $2.38 million +1.4%2.3%7.2 $3.34
8/15/2024701,800 shares $2.24 million +0.1%2.3%6.7 $3.19
7/31/2024701,000 shares $2.33 million +33.0%2.3%6.7 $3.32
7/15/2024526,900 shares $1.70 million -2.1%1.7%4.8 $3.22
6/30/2024538,200 shares $1.19 million -5.0%1.8%6.6 $2.21
6/15/2024566,200 shares $1.48 million +3.2%1.9%6.5 $2.61
5/31/2024548,500 shares $1.33 million -1.1%1.8%5.1 $2.43
5/15/2024554,300 shares $1.62 million -12.3%1.8%5 $2.93
4/30/2024632,100 shares $1.88 million +14.3%2.1%5.3 $2.97
4/15/2024553,100 shares $1.75 million -4.0%1.8%4.6 $3.16
3/31/2024575,900 shares $1.80 million -3.6%1.9%4 $3.12
3/15/2024597,200 shares $2.20 million -3.4%2.0%3.9 $3.69
2/29/2024618,200 shares $2.16 million +8.2%2.1%2.9 $3.50
2/15/2024571,500 shares $2.33 million -16.1%1.9%2.7 $4.08
1/31/2024681,500 shares $3.09 million +1.6%2.3%3.4 $4.54
1/15/2024670,900 shares $2.95 million +10.7%2.2%3.7 $4.39
12/31/2023606,100 shares $2.35 million -8.4%2.1%3.9 $3.88
12/15/2023661,500 shares $2.48 million +14.2%2.2%4.7 $3.75
11/30/2023579,200 shares $1.93 million -1.6%2.0%5 $3.34
11/15/2023588,400 shares $1.69 million -1.2%2.0%12.7 $2.88
10/31/2023595,500 shares $1.88 million -7.7%2.0%12.7 $3.16
10/15/2023645,300 shares $2.16 million +6.1%2.2%12.4 $3.34
9/30/2023608,100 shares $1.99 million -6.0%2.1%7.7 $3.27
9/15/2023647,000 shares $2.12 million +3.3%2.2%8.3 $3.28
8/31/2023626,500 shares $2.30 million -4.0%2.1%8.1 $3.67
8/15/2023652,600 shares $2.41 million -1.6%2.2%8 $3.69
7/31/2023663,000 shares $2.38 million -6.0%2.3%7.5 $3.59
7/15/2023705,300 shares $2.57 million +15.2%2.4%7.4 $3.64
6/30/2023612,400 shares $1.96 million +0.7%2.1%5.7 $3.20
6/15/2023608,400 shares $2.07 million -3.6%2.1%6.6 $3.41
5/31/2023630,800 shares $1.93 million +0.9%2.1%6.5 $3.06
5/15/2023624,900 shares $2.16 million +4.2%2.1%6.3 $3.45
Warren Buffett Bets $40 Billion—You Can Get in for $20 (Ad)

I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in this sector.

Click Here to Get All the Details >>>
4/30/2023599,500 shares $2.45 million +2.3%2.0%6.4 $4.08
4/15/2023586,200 shares $3.50 million +6.9%2.0%7.3 $5.97
3/31/2023548,300 shares $2.36 million +1.2%1.9%9.5 $4.30
3/15/2023541,600 shares $2.26 million -5.6%1.8%10.2 $4.18
2/28/2023573,600 shares $2.54 million -3.1%1.9%12.2 $4.42
2/15/2023592,000 shares $2.46 million +0.8%2.0%13.6 $4.16
1/31/2023587,300 shares $2.57 million -1.1%2.0%13.2 $4.37
1/15/2023594,000 shares $2.97 million +0.2%2.0%11.9 $5.00
12/30/2022592,700 shares $2.52 million -1.9%2.0%11.7 $4.25
12/15/2022604,400 shares $2.51 million -2.0%2.1%8.7 $4.15
11/30/2022616,600 shares $3.11 million -1.0%2.1%6.8 $5.04
11/15/2022622,500 shares $3.12 million -3.1%2.1%6.8 $5.01
10/31/2022642,600 shares $3.60 million -1.3%2.2%6.8 $5.60
10/15/2022650,800 shares $3.14 million +23.9%2.2%7 $4.82
9/30/2022525,400 shares $2.58 million +15.0%1.8%5.5 $4.92
9/15/2022457,000 shares $2.05 million -2.2%1.6%5.5 $4.48
8/31/2022467,200 shares $1.95 million -5.4%1.6%7.5 $4.17
8/15/2022493,600 shares $2.25 million +3.2%1.7%5.9 $4.55
7/31/2022478,100 shares $1.82 million +0.7%1.7%5.6 $3.80
7/15/2022475,000 shares $1.36 million -0.5%1.6%5.1 $2.86
6/30/2022477,400 shares $1.46 million -4.0%1.7%5.3 $3.06
6/15/2022497,500 shares $1.58 million -2.9%1.7%5.6 $3.17
5/31/2022512,500 shares $1.84 million +1.3%1.8%6 $3.59
5/15/2022505,700 shares $1.70 million -12.4%1.8%7.2 $3.37
4/30/2022577,400 shares $1.88 million -10.3%2.0%8.5 $3.25
4/15/2022643,400 shares $1.69 million -4.1%2.2%10.5 $2.62
3/31/2022671,200 shares $1.84 million -0.9%2.3%9 $2.74
3/15/2022677,000 shares $1.69 million +0.1%2.4%7.4 $2.50
2/28/2022676,200 shares $1.88 million -2.7%2.4%5.4 $2.78
2/15/2022695,200 shares $2.18 million -4.2%2.4%5 $3.13
1/31/2022725,800 shares $2.38 million -3.2%2.5%4.9 $3.28
1/15/2022749,800 shares $2.56 million +5.2%2.6%4.5 $3.41
12/31/2021712,900 shares $2.12 million +0.5%2.5%4.4 $2.97
12/15/2021709,200 shares $2.23 million +10.1%2.5%4.6 $3.14
11/30/2021644,000 shares $2.34 million -1.0%2.3%4.3 $3.64
11/15/2021650,800 shares $2.96 million -4.2%2.3%2.9 $4.55
10/29/2021679,400 shares $3.24 million +4.2%2.4%2.8 $4.77
10/15/2021652,100 shares $2.86 million +0.1%2.3%2.6 $4.39
9/30/2021651,500 shares $3.11 million -8.1%2.3%2.3 $4.77
9/15/2021708,800 shares $3.41 million -12.7%2.5%2.5 $4.81
8/31/2021812,200 shares $4.55 million +12.7%2.9%2.9 $5.60
8/13/2021720,600 shares $2.99 million -0.1%2.5%4.1 $4.15
7/30/2021721,500 shares $3.19 million -8.7%2.5%4.2 $4.42
7/15/2021790,000 shares $3.22 million +25.1%2.8%4.9 $4.07
6/30/2021631,400 shares $2.45 million -3.8%2.2%3.3 $3.88
6/15/2021656,400 shares $2.78 million -14.9%2.3%2.5 $4.23
5/28/2021771,400 shares $3.06 million -3.5%2.7%1.4 $3.97
5/14/2021799,600 shares $2.77 million -0.5%N/A1.4 $3.46
4/30/2021803,600 shares $3.83 million +51.9%N/A1.4 $4.77
4/15/2021529,100 shares $2.43 million -18.7%N/A0.8 $4.60
Warren Buffett Bets $40 Billion—You Can Get in for $20 (Ad)

I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in this sector.

Click Here to Get All the Details >>>
3/31/2021650,500 shares $3.17 million +15.0%N/A1 $4.87
3/15/2021565,500 shares $3.30 million +13.6%N/A0.8 $5.84
2/26/2021497,700 shares $2.58 million +3.9%N/A0.7 $5.18
2/12/2021479,200 shares $2.54 million -15.2%N/A0.7 $5.31
1/29/2021564,900 shares $2.03 million -38.2%N/A0.8 $3.60
1/15/2021914,600 shares $4.01 million -17.6%N/A1.4 $4.38
12/31/20201,110,000 shares $3.54 million +53.8%N/A1.9 $3.19
12/15/2020721,700 shares $1.90 million -21.3%N/A1.3 $2.63
11/30/2020916,500 shares $2.55 million +2.6%N/A4.8 $2.78
11/15/2020893,100 shares $1.94 million -22.3%N/A3.9 $2.17
10/30/20201,150,000 shares $2.40 million -14.2%N/A4.9 $2.09
10/15/20201,340,000 shares $3.77 million -12.4%N/A5.1 $2.81
9/30/20201,530,000 shares $3.72 million +0.7%N/A4.9 $2.43
9/15/20201,520,000 shares $3.51 million +11.0%N/A4.6 $2.31

ANIX Short Interest - Frequently Asked Questions

What is Anixa Biosciences' current short interest?

Short interest is the volume of Anixa Biosciences shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 336,300 shares of ANIX short. 1.10% of Anixa Biosciences' shares are currently sold short. Learn More on Anixa Biosciences' current short interest.

What is a good short interest ratio for Anixa Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANIX shares currently have a short interest ratio of 3.0. Learn More on Anixa Biosciences's short interest ratio.

What is a good short interest percentage for Anixa Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.10% of Anixa Biosciences' floating shares are currently sold short.

Is Anixa Biosciences' short interest increasing or decreasing?

Anixa Biosciences saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 336,300 shares, an increase of 4.1% from the previous total of 322,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Anixa Biosciences' float size?

Anixa Biosciences currently has issued a total of 32,180,000 shares. Some of Anixa Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Anixa Biosciences currently has a public float of 30,550,000 shares.

How does Anixa Biosciences' short interest compare to its competitors?

1.10% of Anixa Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Anixa Biosciences: Olema Pharmaceuticals, Inc. (18.15%), Neurogene Inc. (11.26%), Rezolute, Inc. (2.14%), Atyr PHARMA INC (4.45%), Compass Therapeutics, Inc. (2.62%), Atea Pharmaceuticals, Inc. (3.74%), AC Immune SA (1.63%), Canopy Growth Co. (8.33%), C4 Therapeutics, Inc. (12.18%), Candel Therapeutics, Inc. (11.06%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Anixa Biosciences stock?

Short selling ANIX is an investing strategy that aims to generate trading profit from Anixa Biosciences as its price is falling. ANIX shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Anixa Biosciences?

A short squeeze for Anixa Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANIX, which in turn drives the price of the stock up even further.

How often is Anixa Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANIX, twice per month. The most recent reporting period available is December, 31 2024.




This page (NASDAQ:ANIX) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners